<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate a modulating effect of the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (APOE) polymorphism on age at <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: We collected blood samples from 192 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> and typed the APOE polymorphism </plain></SENT>
<SENT sid="2" pm="."><plain>Patients The 192 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> included 59 from the Azores, 73 from mainland Portugal, and 60 from Brazil </plain></SENT>
<SENT sid="3" pm="."><plain>SETTING: Academic research center </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Cases with the ε2/ε3 genotype had an earlier <z:hpo ids='HP_0003674'>onset</z:hpo> compared with those with the ε3/ε3 or the ε3/ε4 genotype </plain></SENT>
<SENT sid="5" pm="."><plain>In this series of patients, the presence of an APOE ε2 allele implies a decrease of nearly 5 years in the age at <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>When combining several other predictors in a general linear model, namely, the presence/absence of the APOE ε2 allele, with the size of the (CAG)(n) in expanded alleles, the model was significantly improved and the explanation of <z:hpo ids='HP_0003674'>onset</z:hpo> variance was raised from 59.8% to 66.5% </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, the presence of the ε2 allele was associated with an <z:hpo ids='HP_0003674'>onset</z:hpo> before age 39 years (odds ratio, 5.00; 95% CI, 1.18-21.14) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The polymorphism at the APOE gene plays a role as a genetic modifier of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> phenotype </plain></SENT>
</text></document>